SPONSOR
Innovent Biologics (Suzhou) Co. Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: HealthyActive Non-segmental VitiligoSevere Alopecia AreataAdvanced Non-Small Cell Lung CancerMultiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Healthy, Active Non-segmental Vitiligo, Severe Alopecia Areata, Advanced Non-Small Cell Lung Cancer.
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Innovent Biologics (Suzhou) Co. Ltd.
How many clinical trials has Innovent Biologics (Suzhou) Co. Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Innovent Biologics (Suzhou) Co. Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Healthy, Active Non-segmental Vitiligo, Severe Alopecia Areata. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Innovent Biologics (Suzhou) Co. Ltd. research focus on?
Innovent Biologics (Suzhou) Co. Ltd. clinical trials span Healthy, Active Non-segmental Vitiligo, Severe Alopecia Areata, Advanced Non-Small Cell Lung Cancer, Multiple Myeloma. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Innovent Biologics (Suzhou) Co. Ltd. clinical trial?
To participate in a Innovent Biologics (Suzhou) Co. Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Innovent Biologics (Suzhou) Co. Ltd. trials with current recruitment status updated daily.
Clinical Trials by Innovent Biologics (Suzhou) Co. Ltd.
NCT07554222 Phase 1
Recruiting
Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
Healthy
NCT05504278 Phase 1
Recruiting
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
Advanced Non-Small Cell Lung Cancer
NCT06083207 Phase 1, Phase 2
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology